Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

Go back to Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
(NASDAQ: MIST) Delayed: 0.80 +0.04 (5.26%)
Previous Close $0.76    52 Week High $ 
Open $0.78    52 Week Low $ 
Day High $0.81    P/E N/A 
Day Low $0.74    EPS $ 
Volume 831,107